Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Pavilion Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Pavilion Capital

Pavilion Capital

Operating

Pavilion Capital: A growth-focused private equity investor, fueling market-leading companies.

Location
New York City, NY, US
Founded
1974
Firm
Compare
Portfolio
Employees
News

Investments

Flare Therapeutics
Flare Therapeutics
Series C

Total Raised

$290M

Rounds

3

Series B$123MMarch 2023
LevitasBio
LevitasBio

Total Raised

$61M

Rounds

3

Series C$35MOctober 2022
Zilliz
Zilliz

Total Raised

$113M

Rounds

4

Series B$60MAugust 2022
Series B$43MNovember 2020
Insilico Medicine
Insilico Medicine

Total Raised

$401.3M

Rounds

11

Series D$35MAugust 2022
Series D$60MJune 2022
Series C$255MJune 2021
Series B$37MSeptember 2019
Series A$6MJune 2018
Moma Therapeutics
Moma Therapeutics

Total Raised

$236M

Rounds

2

Series B$150MMay 2022
Ensem Therapeutics
Ensem Therapeutics

Total Raised

$77M

Rounds

2

Series A$67MApril 2022
Rokt
Rokt

Total Raised

$487M

Rounds

7

Series E$325MDecember 2021
HotSpot Therapeutics
HotSpot Therapeutics

Total Raised

$210M

Rounds

4

Series C$100MNovember 2021
Infinium
Infinium

Total Raised

$69M

Rounds

3

Series Unknown$69MOctober 2021
Allay Therapeutics
Allay Therapeutics

Total Raised

$118.9M

Rounds

4

Series C$86.9MSeptember 2021
Pivot Bio
Pivot Bio

Total Raised

$616.9M

Rounds

7

Series D$430MJuly 2021
Series C$100MApril 2020
NiKang Therapeutics
NiKang Therapeutics

Total Raised

$260M

Rounds

3

Series C$200MMay 2021
Inari Agriculture
Inari Agriculture

Total Raised

$609M

Rounds

7

Series D$208MMay 2021
Blind
Blind

Total Raised

$71.5M

Rounds

8

Series C$37MMay 2021
Schrödinger
Schrödinger
Public

Total Raised

$567.2M

Rounds

10

Series E$25MMay 2019
Soracom
Soracom

Total Raised

$4.4B

Rounds

5

Series B$3BJune 2016